Newsroom

TORONTO--(BUSINESS WIRE)--Altis Labs, Inc. (“Altis”), the AI endpoint company accelerating clinical trials, today announced findings from an independent post-hoc analysis evaluating its AI-powered imaging endpoint, IPRO, in the MARIPOSA Phase 3 trial.1 The findings, which were presented at the World Conference on Lung Cancer (WCLC) 2026 in Seoul, Republic of Korea, show that Altis’ IPRO Response Rate detected an early, notable treatment effect, while RECIST-based objective response rate (ORR) f...

NEW YORK--(BUSINESS WIRE)--WisdomTree, Inc. (NYSE: WT), a global financial innovator, and MoonPay, the global financial technology company powering the movement of value across fiat and digital assets, have announced a strategic collaboration to make the WisdomTree Treasury Money Market Digital Fund (WTGXX), a tokenized money market mutual fund, more accessible to everyday investors in the U.S. via MoonPay. As part of this initiative, MoonPay plans to use WTGXX as part of its stablecoin reserve...

FYRESDAL, Norway--(BUSINESS WIRE)--EdgeConneX®, a global leader in Build-to-Suit and Build-to-Density digital infrastructure solutions, today announced the appointments of Garry O’Leary as SVP, Delivery, Global, Anders Hilt as Vice President of Norway, and Michael Barth as Vice President of Germany. All three hires bring a deep commitment to building strong local relationships and will play a key role in advancing the company's global projects and supporting community engagement and local suppo...

EL SEGUNDO, Calif.--(BUSINESS WIRE)--Todd Parsons appointed CEO of Prodege...

LONDON--(BUSINESS WIRE)--  FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...

SALEM, Ore.--(BUSINESS WIRE)--Agility Robotics, a leading humanoid robotics and physical AI company, today announced that it will host its Analyst & Investor Day on Tuesday, October 6, 2026, beginning at 12:30 p.m. ET in New York City. Following this week’s unveiling of Digit® 5, Agility’s next-generation humanoid robot engineered for cooperatively safe work at scale, the event will provide investors and analysts with a deeper look at the company’s technology, commercial strategy and plans...

NEW YORK--(BUSINESS WIRE)--Privately-owned financial services firm Brown Brothers Harriman (BBH) today announced that Kevin W. Stone has been named Managing Partner, effective January 1, 2027. In this role, Stone will serve as the firm’s chief executive officer, succeeding William B. Tyree. Bill Tyree will step down as Managing Partner following more than 40 years with the firm and will continue to serve as a retired General Partner. BBH is a privately-owned global financial services firm focus...

NOVA YORK--(BUSINESS WIRE)--A IFF (NYSE: IFF), líder global em sabores, fragrâncias e biociências, anunciou hoje o lançamento do Omni-Bos™ PHY, uma nova enzima fitase desenvolvida especificamente para bovinos leiteiros. A tecnologia ajuda os produtores a melhorar o aproveitamento de nutrientes e a eficiência alimentar ao liberar nutrientes presentes na ração, permitindo que as vacas obtenham maior valor dos ingredientes utilizados na alimentação. O Omni-Bos™ PHY será lançado inicialmente nas re...

NUEVA YORK--(BUSINESS WIRE)--IFF (NYSE: IFF), líder mundial en sabores, fragancias y biociencias, anunció hoy el lanzamiento de Omni-Bos™ PHY, una innovadora enzima fitasa desarrollada específicamente para bovinos lecheros. La tecnología ayuda a los productores a mejorar el aprovechamiento de nutrientes y la eficiencia alimentaria al liberar nutrientes presentes en el alimento, permitiendo que las vacas obtengan un mayor valor nutricional a partir de los ingredientes utilizados en la dieta. Omn...

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) — a global leader in flavors, fragrances and health and biosciences — today announced the launch of Omni-Bos™ PHY, a novel phytase enzyme designed specifically for dairy cattle. The technology helps producers improve nutrient utilization and feed efficiency by unlocking nutrients already present in feed, enabling cows to derive greater value from existing feed ingredients. Omni-Bos™ PHY will initially launch in the Middle East, Africa and Asia-Pacific...